Non-Hodgkin Lymphoma | Tumor

CAR T Therapy for Relapsed/Refractory DLBCL: Brian’s Story

November 25th 2020, 5:00am


Outdoor Nighttime Light Increasing the Risk of Non-Hodgkin Lymphoma

November 24th 2020, 10:00pm


We have all been told we should stay off our phone before bed, but this study proves that the outdoor light at night is truly harmful long term and could increase the risk of non-Hodgkin lymphoma.

Rescue Therapy with Bendamustine and Other Agents May Result in High Response Rates in Relapsed or Refractory NHL

November 20th 2020, 2:00pm


This combined treatment, which includes bendamustine, ofatumumab, carboplatin and etoposide, may serve as an effective bridge to stem cell transplantation.

Diagnosing Asymptomatic Cancer With Blood Tests Could Save Lives

November 12th 2020, 10:00pm


Finding cancer may be easier now, as blood tests are being developed to diagnose patients with asymptomatic cancer.

How CAR-T Cell Therapy is Being Used in the Field of Blood Cancer Treatment

November 11th 2020, 7:00pm


CAR-T cell therapy is a relatively new treatment option for patients with blood cancers, but it’s one showing promise across the landscape. Here’s what you need to know.

What’s New in Hodgkin Lymphoma: Expert Gives an Overview

November 6th 2020, 2:00pm


Outcomes for patients with Hodgkin lymphoma continue to improve, thanks to new drugs, according to Dr. Pamela Allen.

Novel Targeted Drugs are Changing the Treatment of Diffuse Large B-Cell Lymphoma

November 5th 2020, 2:00pm


Three targeted drugs have recently been approved to treat diffuse large B-cell lymphoma, broadening the treatment options for patients with this aggressive blood cancer, according to Dr. Germame Ajebo.

Abbreviated Treatment Improves Quality of Life and Appears Safe in Some with Diffuse Large B Cell Lymphoma

October 29th 2020, 9:00pm


Giving fewer courses of chemotherapy and no radiation could become a new standard for patients with stage 1 or 2 diffuse large B cell lymphoma based on the results of a recent study.

CAR-T Cell Therapy Side Effects: Know What to Look Out For

October 20th 2020, 1:00pm


CAR-T cell therapy is drastically improving outcomes for patients with diffuse large B-cell lymphoma. However, the treatment can come with some severe side effects that patients need to know about.

New CAR-T Cell Therapy, Given with Keytruda, Is Safe and Effective in Treating Diffuse Large B Cell Lymphoma

October 13th 2020, 1:00pm


Combining the immunotherapy Keytruda with a CAR-T cell therapy that targets the proteins CD19 and CD22 generates complete responses with minimal side effects, results from an early study demonstrate.